News Outlets Disclose How Drugmakers Co-opt Patient Advocates

by Admin | September 19, 2016 2:35 pm

September 19, 2016—The New York Times and investigative journalists at The Center for Public Integrity have both published recent exposés about how drug companies co-opt patient-advocacy and civic groups to do their bidding with lavish donations. The exposés are timely, as some disease-awareness and concerned-citizens groups are ramping up efforts to get Congress to “reform” the 340B drug discount program[1] into oblivion.  

---

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[2].    Already registered? Click here to login[3]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Source URL: https://340binformed.org/2016/09/news-outlets-disclose-how-drugmakers-co-opt-patient-advocates/

---